Valeant Pharmaceuticals International said today it will boost its offer after Allergan Inc. formally rejected a $46 billion unsolicited takeover bid, the Associated Press reports.
11150 Santa Monica Boulevard, Suite 350
Los Angeles, CA 90025
323-549-5225
© Los Angeles Business Journal